Novo Nordisk A Net Income per Employee (NVO), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Novo Nordisk A  (NYSE: NVO)
 

Novo Nordisk A Net Income per Employee

NVO's Quarterly Results, Trends, Rankings, Statistics
With an income increase of 5.93% in the fourth quarter 2025, year on year to cumulative value of $15,518 million, and with 69,505 employees, Novo Nordisk A's income per employee grew on trailing twelve month basis to $ 223,262, this is below the company average income per employee.
The Healthcare sector has seen employees of 8 other companies achieving higher income per employee. While Novo Nordisk A's total ranking has deteriorated compared to the previous quarter from to 180.


What is Income per Employee Ratio?





Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NVO Net Income per Employee (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Net Income Change 5.93 % - - - -
Net Income per Employee (TTM) $ 223,262 210,767 210,767 210,767 210,767
NVO's Total Ranking # 180 # # # #
Seq. Net Income Change - - - - -

NVO Company Profile >> Back to NVO Efficiency Comparisons >> Compare NVO Net Income per Employee to its Competitors

NVO Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 9
Healthcare Sector # 14
Overall Market # 180

Net Income per Employee Statistics
High Average Low
$ 1,473,764 $ 448,609 $ 84,027
(Dec 31 2025)   (Dec 31 2019)







Companies with similar Income per Employee for 12 month ending Dec 31 2025, within Healthcare Sector Income per Employee Income 12 month ending Dec 31 2025Number of Employees Dec 31 2025
Spero Therapeutics Inc   342,880.00 $ 8.572  Million 25 
Arrowhead Pharmaceuticals Inc   328,514.77 $ 233.574  Million 711 
Alpha Tau Medical Ltd  327,900.00 $ 42.627  Million 130 
Genmab A  317,926.71 $ 963.000  Million 3,029 
Abeona Therapeutics Inc   314,969.03 $ 71.183  Million 226 
Crescent Biopharma Inc   294,505.50 $ 12.958  Million 44 
Regeneron Pharmaceuticals Inc   292,336.15 $ 4,504.900  Million 15,410 
Icecure Medical Ltd  273,763.64 $ 15.057  Million 55 
Dariohealth Corp   252,812.12 $ 41.714  Million 165 
Vaxart Inc   251,184.62 $ 16.327  Million 65 
Merck and Co Inc   243,506.67 $ 18,263.000  Million 75,000 
Interpace Biosciences Inc   240,931.37 $ 24.575  Million 102 
Ironwood Pharmaceuticals inc   240,170.00 $ 24.017  Million 100 
Neurocrine Biosciences Inc   239,300.00 $ 478.600  Million 2,000 
Adma Biologics Inc   227,094.28 $ 146.930  Million 647 
Community Health Systems Inc   218,064.52 $ 676.000  Million 3,100 
Bristol myers Squibb Company  217,076.92 $ 7,055.000  Million 32,500 
Transmedics Group Inc   211,905.35 $ 190.291  Million 898 
Indivior Pharmaceuticals Inc   210,000.00 $ 210.000  Million 1,000 
Lantheus Holdings Inc   195,774.52 $ 233.559  Million 1,193 
Johnson and Johnson  190,369.32 $ 26,804.000  Million 140,800 
Novartis Ag  185,566.05 $ 13,967.000  Million 75,267 
Zoetis Inc   184,344.83 $ 2,673.000  Million 14,500 
Grifols Sa  174,291.94 $ 560.000  Million 3,213 
Puma Biotechnology Inc   173,804.47 $ 31.111  Million 179 
Biogen Inc   172,386.67 $ 1,292.900  Million 7,500 
Intuitive Surgical Inc   169,003.00 $ 2,876.600  Million 17,021 
Kiniksa Pharmaceuticals International Plc  161,215.85 $ 59.005  Million 366 
Sab Biotherapeutics Inc   154,345.15 $ 13.274  Million 86 
Collegium Pharmaceutical Inc   148,628.84 $ 62.870  Million 423 


Date modified: 2026-09-10T03:11:57+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.